If you are not happy with the results below please do another search
Principal Investigator: Martin Zack, Ph.D., Centre for Addiction and Mental Health
Awarded $75,042 in 2000
Aim: Explore the role played by neurochemical activation in the development of gambling addiction.
Principal Investigator: Marc N. Potenza, MD, Ph.D., Yale School of Medicine
Awarded $172,500 in 2000
Aim: Test the short-term tolerability and efficacy of the antidepressant citalopram, naltrexone (a drug used to blunt cravings for alcohol) and a citalopram/naltrexone combination pharmacotherapy in the treatment of dually diagnosed patients with pathological gambling and alcohol abuse or dependence.
Principal Investigator: Donald W. Black, MD, University of Iowa
Awarded $169,929 in 2000
Aim: Understand the role that family history of gambling disorder plays in the development of pathological gambling. The investigator received a major grant from the National Institutes of Health in 2005 to continue the research.
